With inflation and interest rate policies moving in different directions around the world, many investors are looking for ways to stay exposed to growth without taking on excessive balance sheet risk. That is where the Financially Fit Penny Stocks screener comes in, focusing on lower priced companies that aim to pair early stage potential with healthier finances than typical micro caps. This article highlights three stocks from that screener, giving you a clear, practical starting point if you want to explore opportunities that sit between high risk speculation and more mature large caps.

Grab Holdings (GRAB)

Overview: Grab Holdings runs a superapp across Southeast Asia that combines ride hailing, food and package delivery, digital payments, and financial services in one platform, connecting millions of consumers, drivers, and merchants across eight countries.

Operations: Grab generates most of its revenue from Deliveries at about US$1.9b and Mobility at about US$1.3b, with smaller contributions from Financial Services at about US$379m and Others at about US$4m.

Market Cap: US$13.5b

Investors looking at Grab Holdings stock are getting exposure to a superapp that already spans ride hailing, food delivery, payments, and banking services, all built on a sizeable user and merchant base across Southeast Asia. The company is profitable with net profit margins in the low double digits, carries a large cash position, and continues to expand higher margin areas like financial services and advertising, including the planned consolidation of Superbank and the rollout of GrabStays and autonomous ride services with WeRide. The trade off is a relatively high P/E, heavy use of external funding, complex regulation, and a young board. This means the upside case sits alongside governance and funding risks that investors may wish to understand in more detail.

Grab Holdings is already profitable and sitting on substantial cash, but the real story may be how that financial strength affects the balance between its high P/E, regulatory exposure, and funding risks. This is unpacked in the 4 key rewards and 1 important major warning sign

Marqeta (MQ)

Overview: Marqeta is a US based fintech that runs a cloud platform for issuing and processing debit, prepaid, credit, virtual, and physical cards. It gives companies tools to build card programs, manage accounts, and move money through features like early direct deposit, bill pay, and fee free ATMs.

Operations: Marqeta generates about US$651.6m in data processing revenue, with roughly US$551.2m coming from the United States and about US$100.4m from other markets.

Market Cap: US$1.6b

Marqeta stock sits at the crossroads of digital payments, embedded finance, and AI driven risk tools. This positioning is why it stands out in a screener focused on financially stronger smaller companies. The business has posted its first GAAP profit, reports 33% growth in processing volumes and 19% net revenue growth for Q1 2026, and is leaning into Europe with the TransactPay deal and a Banking Circle partnership that opens 30 more countries. At the same time, profit margins are thin, earnings recently deteriorated, and revenue still leans heavily on a few large clients, so concentration and regulatory risk remain front and center. That combination of early profitability, global expansion, and real client dependence makes the full Marqeta story worth a closer look.

Marqeta’s early GAAP profit, growing processing volumes, and global push suggest a story that is only half told, and the real twist sits in the analyst forecasts for Marqeta hiding behind those thin margins and client dependencies

Clover Health Investments (CLOV)

Overview: Clover Health Investments focuses on Medicare Advantage in the United States, offering PPO and HMO plans to Medicare eligible individuals and using its Clover Assistant software to help physicians spot and manage chronic conditions more effectively.

Operations: Clover Health Investments generates around US$2.2b in revenue from its Insurance segment, all from the United States.

Market Cap: US$2.5b

Clover Health Investments brings together a technology driven care model, its Clover Assistant platform, and a pure play focus on Medicare Advantage at a time when value based care and an aging US population are key themes. The recent upgrade of its PPO plans to a 4.5 star rating for 2026, court verified and tied to higher CMS reimbursements, sits alongside revenue of US$749.19m and net income of US$27.33m in Q1 2026, indicating improving business momentum. Set against that are ongoing GAAP losses over recent years, heavy reliance on external funding, regulatory and reimbursement risk, insider selling, and intense competition from larger insurers. How those positives and pressures balance out is where the real Clover story becomes particularly relevant for investors.

Clover Health’s mix of Medicare Advantage focus, Q1 2026 profitability, and past GAAP losses suggests a story that may be turning a corner, but the real inflection is buried in the analyst forecasts for Clover Health Investments

The three stocks covered here are just a starting sample, and the full screener behind the Financially Fit Penny Stocks idea actually identified 326 more companies with equally compelling financial stories and early stage potential, all captured in the Financially Fit Penny Stocks screener. Use Simply Wall St to unlock filters around catalysts, balance sheet strength and the specific narratives that matter to you so you can identify and analyze the penny stocks that best fit your highest conviction ideas.

Take Control of Your Investment Journey

If Marqeta or any of these companies have caught your attention, register for FREE with Simply Wall St and add your companies to a Watchlist to monitor the share price against the fair value and track any new developments as they happen. Once you've made your move, manage your holdings with our Portfolio Command Center that filters out the noise to deliver only the most critical, actionable updates. Throughout your journey, our Community allows you to filter the best ideas from thousands of investor perspectives. By uncovering hidden catalysts and risks early, you'll accelerate your decision-making and stay one step ahead of the market.

Seeking Fresh Alternatives Beyond Today?

Fresh ideas do not stay under the radar for long. Spot potential breakouts while momentum is building and information is still sharp. Before the crowd reacts, act now.

• Spot income workhorses built for staying power and scan 9 dividend fortresses that aim to keep cash flowing even when headlines are flying.
• Chase tomorrow's infrastructure backbone and review 48 AI infrastructure stocks quietly powering the compute, networking, and data needs behind AI demand while it still matters.
• Track under the radar compounding potential and check 20 high quality undiscovered gems that pair cleaner balance sheets with grounded fundamentals before attention floods in.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.